Prudential plc (PUK) AI Stock Analysis

Headquartered in London, UK, Prudential plc operates through its subsidiaries to provide life and health insurance, retirement solutions, and asset management services primarily in Asia and Africa. Founded in 1848, the company offers health and protection products alongside participating, linked, and traditional savings plans. Its insurance coverage includes critical illnesses such as cancer, stroke, and heart attack, as well as tropical disease protection for dengue, malaria, and measles. Prudential also manages diverse investment strategies across equity, fixed income, multi-asset, quantitative, and alternative investments for both institutional and individual clients.

Annual revenue has fluctuated across recent fiscal cycles, falling 26.9% in FY2021 to $26.50B, dropping 67.0% to $8.75B in FY2022, rising 36.9% to $11.97B in FY2023, and decreasing 32.0% to $8.14B in FY2024 before increasing 241.3% to $27.78B in FY2025. Net income moved from $2.21B in FY2021 to -$1.01B in FY2022, before recovering to $1.70B in FY2023, $2.29B in FY2024, and $3.98B in FY2025 with a net margin of 14.3%. Over the five years from FY2020 to FY2025, revenue experienced a CAGR of -5.2%. For the latest quarter ended June 30, 2026, quarterly revenue fell 1.8% year-over-year, while quarterly earnings declined 23.0%.

As of June 30, 2026, Prudential held $5.89B in cash and short-term investments against total debt of $5.43B, resulting in a net cash position of $456.0M. Total assets stood at $223.68B and shareholders' equity was $19.80B, with a debt-to-equity ratio of 0.27 and a current ratio of 5.53. In FY2025, the company generated $2.28B in operating cash flow and $2.17B in free cash flow. Capital allocation in FY2025 included $104.1M in capital expenditures, $1.25B in share buybacks, and $594.6M in dividends paid.

Prudential trades at a trailing P/E of 8.5x and a forward P/E of 9.7x, both below the median of its US-listed Financial Services peers of 12.1x and 10.8x, respectively. The company's price-to-sales ratio of 2.1x is also below the peer median of 3.2x, based on a market cap of $29.64B and an enterprise value of $31.16B. Over the past year, the stock returned -8.2%, underperforming the S&P 500 (SPY) return of 16.8%. Over a five-year period, the stock fell 35.2%, while the S&P 500 rose 83.0%.

Prudential pays a semiannual dividend with an annual forward payout of $0.56 per share, corresponding to a dividend yield of 2.30%. The company has maintained consecutive dividend payments for 27 years, supported by an 18.7% payout ratio. Over the past five years, annualized dividend growth was -4.6%. The company's most recent ex-dividend date was September 11, 2026.

Wall Street analyst coverage includes 3 Strong Buy ratings and 1 Buy rating, with no Hold, Sell, or Strong Sell recommendations. The mean price target is $38.05, representing a 57.7% premium over the last closing price of $24.13. For the fiscal year ending December 31, 2026, consensus estimates point to revenue of $9.25B and EPS of $1.56, an estimated EPS decline of 22.9%. Four analysts covering next fiscal year project revenue of $10.23B and EPS of $1.61. Prudential has beaten EPS estimates in 1 of the last 4 quarters.

This page is an AI-written research summary of Prudential plc (PUK). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: PUK income statement, PUK balance sheet, PUK key metrics, PUK analyst forecast, PUK chart. See the PUK stock overview for the latest quote and news.